The Wall Street Journal
Pfizer Inc. temporarily halted enrollment of new patients in a clinical
trial of an experimental lung-cancer drug, saying the drug was
associated with a higher rate of adverse events, including fatalities,
than for patients who didn't get the drug... Read More (access restricted)
Find a Doctor/Researcher
Make an Appointment
Refer a Patient
Make a Gift
Penn Cancer Network
